UBS Group’s Integrated Wellness Acquisition Corp Units, each consisting of one Class A ordinary share and one-half of one redeemable warrant WEL.U Stock Holding History

UBS Group’s Portfolio WEL.U Stock Details WEL.U Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-100	Closed	-$1.12K	–	10607
2023 Q3	$1.12K	Buy	+100	New	+$1.12K	﹤0.01%	8089
2023 Q1	–	Sell	-224	Closed	-$2.3K	–	11582
2022 Q4	$2.3K	Hold	224	–	–	﹤0.01%	9703
2022 Q3	$2K	Hold	224	–	–	﹤0.01%	9893
2022 Q2	$2K	Hold	224	–	–	﹤0.01%	9774
2022 Q1	$2K	Sell	224 -1,100	-83%	-$11.1K	﹤0.01%	9819
2021 Q4	$13K	Buy	+1,324	New	+$13.3K	﹤0.01%	8529

Other funds holding WEL.U

TRCT

Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return

UBS Group's WEL.U Position: Q4 2023 in Review

UBS Group sold out of Integrated Wellness Acquisition Corp Units, each consisting of one Class A ordinary share and one-half of one redeemable warrant (WEL.U) in Q4 2023, closing a stake of 100 shares — an estimated $1.12K sold.

UBS Group first reported a position in WEL.U in Q4 2021 and held it in 6 quarters. The position peaked at $13K in Q4 2021. 1 fund tracked by Wall St. Rank holds WEL.U as of Q4 2023.

UBS Group reported no remaining Integrated Wellness Acquisition Corp Units, each consisting of one Class A ordinary share and one-half of one redeemable warrant position as of Q4 2023 after selling out during the quarter.
UBS Group sold 100 Integrated Wellness Acquisition Corp Units, each consisting of one Class A ordinary share and one-half of one redeemable warrant shares in Q4 2023, an estimated $1.12K.
UBS Group first reported a position in Integrated Wellness Acquisition Corp Units, each consisting of one Class A ordinary share and one-half of one redeemable warrant in Q4 2021 and held it in 6 quarters.
UBS Group's Integrated Wellness Acquisition Corp Units, each consisting of one Class A ordinary share and one-half of one redeemable warrant position peaked at $13K in Q4 2021.
1 fund tracked by Wall St. Rank held Integrated Wellness Acquisition Corp Units, each consisting of one Class A ordinary share and one-half of one redeemable warrant as of Q4 2023.

Based on UBS Group's 13F filing for Q4 2023, filed 9 Feb 2024.